Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

N
Nadal M. V. - Effects of factor VIII (fVIII) levels and activated partial thromboplastin time (aPTT) in activated protein C resistance (APC-R) ratio using two different methods
  - Behaviour of the protein C (PC)/protein S (PS) ratio in patients with thrombosis
  - Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
Nadal T. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Nadal M. V. - Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
  - Fibrinolytic activity and response to venous occlusion in activated protein C resistance phenotype
Nadal Seillant M. - Platelet von Willebrand factor antigen (VWF:Ag-i) in patients with mucocutaneous bleeding tendency and normal von Willebrand factor (VWF) plasma levels
NAD'Ali F. - Effect of ergometric exercise on factor VIII coagulant activity in patients with mild and moderate hemophilia A
Nadar S. - Platelet activation and morphologic changes in hypertension
  - Platelet P-selectin and target organ damage in hypertension
Nadar S. - Increased platelet adhesion in metastatic cancer
Nadifi S. - Prevalence of methylenetetrahydrofolatereductase (MTHFR) gene polymorphism (C677T) in the Moroccan population
Nadir Y. - Hemostatic balance on leukemic cells surface – role of TF and uPAR
Nadvaev A. - Crystal structure at 1.7 A of aggretin, a heterodimeric C-type lectin snake venom protein
Naemura A. - Effect of a nitric oxide donor on platelet reactivity and spontaneous thrombolysis in patients with chronic renal failure
  - Effect of ADP P2Y12 receptor inhibition on thrombosis and bleeding measured using guinea pigs
Nafissi N. - Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families
Nafissi Z. - Psychosocial aspects of inherited bleeding disorders among Iranian patients
Nafissi N. - Rapid analysis of the HindIII/intron 19 polymorphism within the human factor VIII gene by ARMS/PCR method
Nagahama Y. - Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Nagai N. - Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Nagai T. - A novel ELISA method for soluble fibrinogen and fibronectin complexes (FG–FN) in normal adult's and DIS patient's plasma
Nagaizumi K. - Roles of the individual g-carboxyglutamic acid residues of factor VII
Nagakawa P. A. - A proposed mechanism for reduced bleeding of direct thrombin inhibitors as compared to heparin as measured by thromboelastography
Naganuma Y. - Platelet endothelial cell adhesion molecule-1 (PECAM-1) of platelets is cleaved under high shear stress
Nagao T. - Correlation between anti-coagulant therapeutic range and Prothrombin Fragment 1 + 2 in Japanese patients with Cardioembolic Stroke
Nagasawa T. - Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Nagashima M. - Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Nagaswami C. - Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
  - A monoclonal antibody to the fibrinogen g chain alters clot structure and properties by producing thinner fibrin fibers arranged in bundles
Nagata K. - Ligand for peroxisome proliferator-activated receptor-a (PPARa) Down-regulates tumor necrosis factor - a-induced pro-coagulant activation of tissue factor through inhibition of ap-1-dependent gene transcription in human endothelial cells
Nagle A. J. - Probabilistic modeling of population-based epidemiology and treatment modalities to determine unconstrained factor VIII demand
Nagler A. - Prevalence of circulating procoagulant microparticles in allogeneic stem cell transplantation (alloSCT) for hemato-oncological malignancies
Naglieri E. - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Nagy Z. - Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
Naik M. U. - Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Naik U. P. - Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Naik M. U. - Calcium- and integrin-binding (CIB) protein is required for platelet spreading on immobilized fibrinogen: functional association of CIB with GPIIb/IIIa
Naik U. P. - Calcium- and integrin-binding (CIB) protein is required for platelet spreading on immobilized fibrinogen: functional association of CIB with GPIIb/IIIa
Naimushin Y. A. - Ligand binding to GP IIb–IIIa and stimulation of platelet release reactions
Nair S. - Glanzmanns thrombasthenia in Indians – how different it is from other ethnic groups
Naito S. - Synthetic inhibitors of coagulation factor Xa suppress thrombin generation without affection on initial thrombin forming time
Naka H. - Hemophilia A gene therapy using the third-generation lentiviral vector – Mouse model
Nakabayashi T. - Synthetic inhibitors of coagulation factor Xa suppress thrombin generation without affection on initial thrombin forming time
Nakagaki T. - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
  - Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
Nakagawa K. - Involvement of VEGF-C/flt-4 system in therapeutic angiogenesis of FGF-2 gene transfer in murine ischemic hind limb
Nakagawa P. - Paradoxical effect of Factor XIII replacement on clot initiation
  - The laboratory evaluation of aspirin-resistance in normal, healthy subjects
Nakahara M. - Degradation pathway of the naturally occurring mutants of protein C and plasmin inhibitor by the proteasome
Nakamura T. N. - The possible role of calpain in cancer mediated vascular endothelial cell (vEC) retraction
Nakamura S. - New functions of neutrophils in inflammation: tissue factor-triggered clotting induction and elastase-mediated fibrinolysis
Nakamura S. - Nonmethylated status of promoter CpG islands in human tissue factor gene
  - Androgen receptor-mediated suppression of tissue factor gene expression in male reproductive organs
Nakanishi Y. - Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Nakano S. - Effect of KFA-1982, a new orally active factor Xa inhibitor, in a rabbit venous thrombosis model
Nakano T. - Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
Nakano M. - C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Nakao S. - Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
  - Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
  - Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
Nakashima Y. - Involvement of VEGF-C/flt-4 system in therapeutic angiogenesis of FGF-2 gene transfer in murine ischemic hind limb
  - Immunohistochemical expression of interleukin-10 (IL-10) in atherosclerotic intimas of human coronary arteries
Nakatani T. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Nakatomi Y. - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
Nakazawa F. - An intracellular cofactor of Factor VII activating protease (FSAP) functions as an initiator of blood coagulation
Nakazawa F. - Degradation pathway of the naturally occurring mutants of protein C and plasmin inhibitor by the proteasome
Nakov R. - Phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis
Nalbone G. - Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Namba M. - Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Nanda N. - CD84 signaling is a novel platelet stimulatory mechanism that occurs during platelet aggregation
Naohiro K. - Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Naoki U. - ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Napoleone E. - Tissue factor expression by human endothilial cells is down-regulated by antagonists of the renin-angiotensin system
Napoleone E. - Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
  - Resveratol and quercetin inhibit tissue factor expression in vascular cells by preventing IkappaBalpha degradation and c-Rel/p65 activation
Narasaki R. - Affinity-trap protease reactor for single-step conversion/purification of angiostatin from human plasma
Nardi M. T. - Management of hospitalized patients with suspected deep vein thrombosis
Narhi L. - Kozak sequence polymorphism of the platelet glycoprotein Ibalpha gene and Thr789Ala polymorphism of the von Willebrand factor gene in fatal CAD
  - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Nash G. B. - Conditioning of endothelial cells by different levels of fluid shear stress modulates their ability to induce each stage of neutrophil adhesion and migration in response to TNF-a but not IL1-b
Nash G. - Blood transfusion is associated with an enhanced pro angiogenic state
Nash G. B. - Neutrophils recruited by TNF-a stimulated endothelial cells down regulate subsequent endothelial VCAM-1 expression and inhibit the adhesion of a secondary bolus of flowing peripheral blood lymphocytes
Nash M. - A proposed ISTH revised classification for the anti-phospholipid syndrome
Nash G. B. - Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
  - Endothelial cells cocultured with monocytes are activated to support the adhesion of flowing leukocytes by a combination of TNF-a IFN-g and TGF-b1, a process that is progressively ablated as monocytes differentiate into macrophages
Nash M. - Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and antibeta2GPI antibodies
Nash G. - Sequential adhesion of platelets and then leukocytes from blood flowing over collagen in simple laminar and disturbed flow
Nasir F. - Blood transfusion is associated with an enhanced pro angiogenic state
Nasissi N. - Reporting presence of 9 novel mutations in hemophilia B patients in Iran
Nasl C. - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
  - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
Nassonov E. - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Natella F. - Antioxidant effect of wine in human: role of polyphenols
Nath E. - Anticoagulant prophylaxis usage in cancer patients undergoing treatment
Naud S. - Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
Naud S. J. - Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
Naud S. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Naumnik B. - Induction of serum hepatocyte growth factor/activin/follistatin system during enoxaparin-anti-coagulated hemodialysis
Naumnik B. - Relation between circulating endothelial markers and anti-coagulation with different heparins in hemodialysis patients: a prospective study
Navaglia F. - Factor VII deficiency associated with severe hemophilia A
Navale L. - Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in pediatric previously treated patients (PTPs)
Navaneetham D. - Factor XI-activation by thrombin on activated platelets requires both anion binding exosites I and II
Navarro S. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
Navarro G. - PROS1 mutations that introduce a premature termination codon explain protein S deficiency by nonsense-mediated mRNA decay
Navarro S. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene reduces the risk of venous thromboembolism in carriers of the factor V Leiden mutation
Navarro M. - Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
Navarro S. - Circulating activated protein C in Behcet's disease and risk of thrombosis
Navdaev A. - Labrirhagin, a protein with metalloprotease and disintegrin domains from Trimeresurus albolabris venom, activates platelets by a mechanism involving GPVI, aIIbbIII3
Navdaev A. - Cross-linking of GPIb by echicetin/biotinylated-IgMk/avidin induces strong GPIIb/IIIa activation and platelet aggregation
Navickis R. J. - Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis – a meta-analysis
Nawroth P. P. - Commercially available protein infusion solutions can be modified by nonenzymatic glycation which causes NFkappaB-dependent expression of procoagulant and inflammatory gene products
  - Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Naylor A. R. - The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
Nazarko J. - Thrombolytic effect of AT1 receptor antagonists – losartan and its metabolite EXP 3174 in rat
Nazeyrollas P. - Increasing the dosage of aspirin before percutaneaous coronary intervention: is there any effect in aspirin resistant patients? A randomized study
Necciari J. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Nedelec J. - A dedicated system for standardized measurement of VASP phosphorylation in blood platelets and detection of thienopyridine resistance
Needham J. - Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
  - Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Needham J. - TAFI antigen levels in local hemophilia A and vWD population
  - Hypercoagulability in inflammatory bowel disease
  - Effect of warfarin anticoagulants on elements of the tissue factor pathway and other procoagulant markers
Neerman-Arbez M. - Congenital afibrinogenemia: expression and analysis of novel mutations affecting fibrinogen assembly or secretion
  - Molecular analysis of factor XI deficiency in 8 Lebanese families: identification of two novel mutations
Negrescue E. - Regulation of megakaryocyte polyploidization and platelet release by the cytoplasmic tail of glycoprotein Iba
Negri E. - Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Negrier C. - Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in surgical settings
  - Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
  - Human factor IX expression in megakaryocytes derived from electrophorated human hematopoietic cells
Negrier N. - Thrombin generation in von Willebrand diseases
Negrier C. - Three abnormal patterns for inversion breaking intron 1 of the FVIII gene
  - Efficacy and safety profile of rAHF-PFM in the surgery setting
Négrier C. - Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Negrier C. - Thrombin Generation Assay: Using Bedside Monitoring as a Dosage Guidance
Negrier C - Current processes and the future of manufacturing for recombinant clotting factors
Négrier C. - Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
Negrier C. - Clinical manifestation of severe hemophilia B ameliorated by Prothrombin 20210A
  - In vitro flow cytometry and functional testing of fresh and cryopreserved platelets
  - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
  - Determination of effective concentrations of recombinant factor VIIa (rFVIIa) for Glanzmann thrombasthenia patients by using thrombin generation in platelet-rich plasma (PRP) and platelet-poor plasma (PPP)
  - Comparison of Clauss fibrinogen and fibrinogen measurement derived from aPTT and PT in diabetes mellitus and correlations with markers of glycemic equilibration
Négrier C. - Treatment of patients with inhibitors with FEIBA: the French experience from 1995 to 1999
Negrotto S. - Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Negrotto S. - Characterization of the von Willebrand factor present in circulating PMN
Negrouk G. - Protection of a chimeric antihuman tissue factor monoclonal antibody against tissue factor-induced acute thrombosis in mice
Nehmiz G. - Pharmacokinetics of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, in patients undergoing hip replacement
Neil M. - A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery
  - An evaluation of preoperative hemostatic variables as risk factors for deep venous thrombosis after elective lower limb arthroplasty
Neill E. - Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Neilsen G. L. - Recombinant factor VIIa in management of acute CNS and GI bleedings during warfarin thromboprophylaxis: clinical and biochemical aspects
Nel M. J. - Ethnic differences in the frequencies of polymorphisms of protein S and protein C in South African populations
Nelissen R. G. H. H. - Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Nelson T. - Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
Nelson E. J. R. - Three novel missense mutations in the b-propeller domains of GPIIb (aIIb integrin) among three unrelated patients with Glanzmann thrombasthenia from southern India
Nemerson Y. - Role of Blood–Borne Tissue Factor in Thrombus Propagation
Nemerson Y. - Induction of fractalkine by endothelial cells under shear stress
Nemery B. - Role of pulmonary inflammation on the peripheral thrombotic risk following intratracheal instillation of diesel exhaust particles
  - Diesel exhaust particles deposited in the lung enhance thrombus formation in peripheral vessels in an in vivo model of vascular thrombosis
Nemmar A. - Diesel exhaust particles deposited in the lung enhance thrombus formation in peripheral vessels in an in vivo model of vascular thrombosis
  - Role of pulmonary inflammation on the peripheral thrombotic risk following intratracheal instillation of diesel exhaust particles
Nemtsova V. - The influence of cyclooxygenase-2-selective nonsteroid anti-inflammatory drugs on bleeding complications in aspirin users
  - Effect of etanercept on procoagulant activity and fibrinolysis in patients with rheumatoid arthritis
Nenci G. G. - Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants: a case-control study
  - Oral anti-coagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS)
  - Interaction between thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anti-coagulant treatment
Nerme V. - Carboxypeptidase U (TAFIa) prevents fibrinolysis from proceeding into the propagation phase through a threshold-dependent mechanism
Nesbitt I. M. - Profile of mutations in a UK hemophilia A patient population
Nesbitt I. M. - Characterization of mutations in a cohort of type 2 von Willebrand disease patients
Nesbitt I. M. - A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
Nesbitt W. S. - Signaling events underlying thrombus formation
Nesheim M. - A study of the protection of plasmin from antiplasmin within an intact fibrin clot during the course of clot lysis
Nesheim M. E. - A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) assembly
  - Polymorphisms in the 3'-untranslated region of the TAFI mRNA modulate TAFI gene expression through control of mRNA stability
  - Molecular dissection of the human TAFI promoter
  - Effect of polymorphisms in the human TAFI 5'-flanking region on TAFI promoter activity
  - The prothrombinase enhancing activity exhibited by VLDL derived from patients with the biphasic APTT waveform is due to increased anionic phospholipid exposure
  - Factor Xa is profoundly protected from Antithrombin–arixtra and antithrombin-Lovenox when incorporated into the prothrombinase complex
  - Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Nesova T. - Complex of Glycoprotein IIb/IIIa – von Willebrand factor (GP IIb/IIIa-vWF) in blood of patients with ischemic heart disease
Nestoridi E. - Globotriasylceramide (Gb3) and blood-borne tissue factor (TF) colocalize with platelets during platelet adhesion/aggregation onto a collagen-coated surface exposed to flowing blood
Nestoridi E. - Shiga toxin with antecedent TNF-a induces enhanced tissue factor activity on human glomerular, but not on umbilical vein, endothelial cells
Netiazhenko V. Z. - Coagulation, fibrinolysis and platelet activity in aspirin-naive and prior aspirin users unstable angina patients, treated with unfractionated heparin
  - Coagulation, fibrinolysis and platelet activity in aspirin-naive and prior aspirin users unstable angina patients, treated with unfractionated heparin
  - Coagulation, fibrinolysis and platelet activity in aspirin-naive and prior aspirin users unstable angina patients, treated with unfractionated heparin
Neubauer I. - Additive anti-angiogenic effects of trapidil and cyproheptadine in the chick area vasculosa angiogenesis model
Neumann F. J. - Tissue factor stimulates migration by activation of the mitogen-activated proteinkinase p38 and the GTPase Rac1
Neumann H. A. M. - Local changes in coagulation and fibrinolysis in patients with a previous deep venous thrombosis
Neumann F.-J. - Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Neumivakin L. V. - Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Neundörfer B. - Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Neville B. - Species dependence on nitric oxide generation: pharmacological implications on animal modeling
Newall F. - Thrombolytic therapy with tissue plasminogen activator (tPA), analysis of safety and outcome in children
  - Reference ranges for hemostatic parameters in children
  - Arterial thromboembolic disease in infants and children
Newall F. - Anti-coagulation clinics for children achieve improved warfarin management
Newall F. - Prospective cohort study of paediatric venous thrombosis
Newhart A. - Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
  - Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
Newman D. K. - Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Newman P. J. - Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Newman P. - PECAM-1 as a regulator of endothelial cell survival
Newman D. K. - Juxtaposition of phosphoserine and tyrosine in the Platelet Endothelial Cell Adhesion Molecule (PECAM)-1 C-terminal Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) allows ITIM tyrosine phosphorylation but bars binding of the phosphatase, SHP-2
Newman P. J. - Juxtaposition of phosphoserine and tyrosine in the Platelet Endothelial Cell Adhesion Molecule (PECAM)-1 C-terminal Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) allows ITIM tyrosine phosphorylation but bars binding of the phosphatase, SHP-2
Newton A. - Protein–protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA-binding
Ng H. - Patterns of cases and impact of venous thromboembolism (VTE) in a tertiary institution in Singapore: defying notions of VTE as a disorder of lower significance among Asians
Ng G. M. - Clinical profile of rare coagulation disorders in an Asian population
Ng B. L. - Coagulation and fibrinolysis during the menstrual cycle and the effects of increased body mass index
  - Plasminogen activators, plasminogen activator inhibitor-1 and D-dimer levels in gynecological cancer
Ng H. - Thrombotic events associated with the use of recombinant factor VIIa in a single institution: a role for caution
Nguyen V. H. - Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Nguyen F. - In terms of clinical impact, thromboplastins with an ISI close to 1 yield better results than thromboplastins with an ISI close to 2, in an external quality control campaign
Nguyen T. - The effect of dietary vitamin K1 on warfarin maintenance dose requirements
Nguyen P. - Thrombinography can differentiate bleeding from nonbleeding patients with prolonged APTT
Nguyen L. H. - Effects of full and partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II on the inhibition of thrombin and activated protein C
Nguyen P. - Platelet function peculiarities throughout childhood: a flow cytometric study from healthy premature new-borns up to 15-year-old-children
Nguyen N. - Plasma hemostatic markers in patients with malignancy: correlation with tumor progression and response to treatment
Nguyen P. - Increasing the dosage of aspirin before percutaneaous coronary intervention: is there any effect in aspirin resistant patients? A randomized study
Nguyen N. - Plasma markers of hemostatic activation in patients with cancer and deep venous thrombosis
Ni H. - Increased fibronectin secretion but not cell surface expression in thrombin-activated platelets of hypofibrinogenemia patients
Ni H. - Autoantibodies to recombinant PSI domain but not to cytoplasmic tail of beta3 integrin cause immune thrombocytopenia
Nicham F. - Evaluation of automated measurement of ristocetin cofactor activity of von Willebrand factor on STA-R® in von willebrand disease: study in 154 patients
  - Analytical validation of the automated measurement on STA-R of the ristocetin cofactor activity (VWF:RCo) of von Willebrand factor
Nichols T. C. - Cloning and expression of full-length recombinant porcine von Willebrand factor
  - Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
  - Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Nichols W. L. - Variability of clinical laboratory practice in testing for disorders of platelet function: results of a NASCOLA survey
Nichols T. C. - The development of pro-hemostatic lyophilized platelets with minimized risk for intravascular coagulation
Nicolaes G. A. F. - Changed inactivation pathway of factor Va by activated protein C in the presence of heparin
Nicolaes G. A. F. - Inefficient secretion and intracellular degradation of factor V
  - H1299R mutation results in retention of mutant factor V molecule in the Golgi complex: a possible novel type of quantitative defect
  - Impaired anticoagulant activity of factor V accounts for a large fraction of the APC resistance associated with the FV Leiden (R506Q) and R2 (H1299R) mutations
  - Identification of the multimerin binding region within the C2 domain of human factor V using constructs generated by alanine scanning and site-directed mutagenesis
  - Theoretical and experimental investigation of the D2194G subsitution in the C2 domain of coagulation factor V
  - Functional properties of recombinant factor Va mutated in a potential calcium-binding site
  - Functional characterization of recombinant factor V molecules mimicking the R2-haplotype
Nicolini A. - 1286 prospective consecutive cases of venous thromboembolic disease at the single venous thromboembolic Unit of Reggio Emilia
Nielsen J. D. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
  - In vitro effect of recombinant activated factor VII on thrombin generation and clot formation in blood from patients on vitamin K-antagonist therapy
Niemela K. - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Niermann D. - Induction of monocytic tissue factor (TF) expression: an additional mechanism of action of desmopressine acetate (DDAVP)
Niesen T. - Influence of anti-thrombin on platelet adhesion onto immobilized fibrinogen in simulated low flow in vitro system
Nieswandt B. - Inhibition of metalloproteases during platelet storage leads to better platelet recovery and improved platelet function upon transfusion
  - Normal arterial thrombus formation in integrin a2-deficient mice
  - Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
  - Glycoprotein Ib and integrin a IIbb 3 contribute to GPVI-dependent vWF-collagen induced thrombus formation under flow
  - Collagen-platelet interactions in vivo
Nieuwenhuis H. K. - Recombinant factor VIIa restores adhesion and aggregation of a IIbb 3-deficient platelets in vitro
  - Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting factor Xa, but not by those inhibiting thrombin or tissue factor
  - The relation between clinical phenotype and genotype of severe hemophilia A
Nieuwland R. - Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
  - Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
  - Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
  - Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin layer chromatography
  - Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
  - Recombinant truncated tissue factor triggers coagulation in normal human plasma via the extrinsic pathway
  - Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Niglio A. - Increased intima-media thickness to show relationship between atherosclerosis and inflammation in a human model: patients affected by rheumatoid arthritis and absence of common markers of atherosclerosis
Niitsu Y. - Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Nijhuis S. - The calibrated Thrombogram: exact monitoring of thrombin generation in clotting platelet rich- and platelet poor plasma
Nijs A. - A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin
Nikiforov A. M. - Unusual persistent cell damages in irradiated rat endothelium as a model in study pathophysiology of atherosclerosis and thrombosis
Nikolaidis G. - Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
  - Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
  - Obesity and coagulation. Is there any correlation?
  - Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
Nikolic N. - Analytical comparison of recombinant and plasma-derived activated protein C (APC)
Nikus K. - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Nilsen D. W. T. - Changes in homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids (PUFAs) administered after an acute myocardial infarction
  - Tissue factor is a major determinant of thrombogenicity following an acute myocardial infarction
Nilsson T. - Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
Nilsson G. - Global hemostatic tests, protein C and anti-thrombin in the intensive care unit setting; correlations and ability to predict outcome
Nilsson P. E. - Prolonged prophylaxis against VTE with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study
Nilsson T. - A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
Nimjaroenniyom N. - The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome
Ninet J. - Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Ning G. - Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Nishino M. - Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
  - Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
Nishioka J. - Decreased expression of protein C inhibitor in renal cell carcinoma cells is partly caused by DNA methylation
  - Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Nishioka J. N. - Usefulness of fully automated measurement of reticulated platelet using the whole blood
Nishiya K. - Factor V C2 domain contains major binding site for thrombin
  - The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
  - M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Nitsche A. - The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Niwaya K. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Nix B. - Platelet aggregation and ATP release in whole blood for diagnosis of bleeding disorders
Nobile De Santis M. S. - Intruterine Growth Restriction (IUGR) and thrombophilic polymorphisms
Nobori T. - Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Nobori T. N. - Frequency of biphasic transmittance waveform in the APTT coagulation assay in the patients with underlying diseases of DIC
  - Usefulness of fully automated measurement of reticulated platelet using the whole blood
Nobori T. - Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Noel A. - Plasminogen activator inhibitor PAI-1 as a regulator of urokinase in angiogenesis
Nogami K. - Factor V C2 domain contains major binding site for thrombin
Nogueiras T. - rFVIIa (Novoseven®) in the treatment of Glanzmann's Thrombastenia
  - Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
Noguti M. A. E. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Nokes T. - Dramatic improvement in the care and management of patients with DVT in a large UK hospital
Nolasco L. - Peptides from the C-terminal regions of ADAMTS-13 specifically block cleavage of ultra-large von Willebrand factor multimers on the endothelial surface under flow
Nolen J. D. L. - Single-dose use of recombinant factor VIIa (NovoSeven) for correction of hepatic-induced coagulopathies prior to minor, invasive procedures
  - Use of constant infusion of recombinant factor VIIa (NovoSeven) in the management of a recurrent subdural hematoma in a patient with severe hepatic coagulopathy
Nomura S. - Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Nomura M. - Differences in perioperative coagulation between Japanese and other ethnic groups undergoing laparoscopic cholecystectomy
Nonne C. - Evidence for a PLCg2-independent alpha2beta1-triggered signalling pathway contributing to platelet aggregation in response to collagen
Nony E. - Comparability study of two purification processes of a plasma-derived anti-thrombin
Nordenhem A. - The t-PA/PAI-1 complex in plasma in relation to risk of myocardial infarction as evaluated in the Stockholm heart epidemiological program (SHEEP)
Nordenhem A. - Prospective evaluation of t-PA/PAI-1 complex predicting myocardial infarction in controls included in the SHEEP study
Norstrøm E. - Inhibition by prothrombin of individual activated protein C-mediated cleavages in factor Va
  - Effects of protein S and phospholipid on individual APC-cleavage sites in factor Va
  - Effects of Factor Xa and protein S on the individual APC-cleavage sites of factor Va
Norstrom E. - Gla-domain mutated human protein C demonstrating enhanced inactivation of both factor Va and factor VIIIa
  - Functional characterization of recombinant Factor V Liverpool: Ile350Thr, a novel mutation associated with thrombosis
  - Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
North R. A. - Inherited thrombophilias are not increased in ‘idiopathic’ small for gestational age pregnancies
Nortier J. W. R. - Incidence of thrombosis in gastro-esophageal cancer: a cohort study of 649 patients
Nosaka S. - Different distribution of antithrombin and thrombomodulin in endotoxin-treated rat: effect of antithrombin and activated protein c concentrates and nafamostat mesilate
Nosál M. - Is infection a risk factor of acute ischemic stroke?
Notø A. T. W. - Interactions between tissue factor pathway inhibitor (TFPI) and lipoprotein lipase (LPL) in metabolism of very low density lipoproteins (VLDL)
Notø A. - Inflammation and endothelial dysfunction in patients with carotid stenosis
Notley C. R. P. - Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
Notley C. - The type 1/type 2M von Willebrand disease dilemma: findings from the Canadian Type 1 VWD study
Notley C. - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
Notoya A. - Synthetic inhibitors of coagulation factor Xa suppress thrombin generation without affection on initial thrombin forming time
Nounou M. - Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Novakova I. R. O. - The Nijmegen low-titer factor VIII inhibitor assay: a highly sensitive assay for the detection of low-titer factor VIII inhibitors
  - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
  - Higher reticulated platelet counts and enhanced expression of P-selectin in patients with immune thrombocytopenic purpura compared to patients with myelodysplastic syndromes
  - Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates
  - Long-term in vivo platelet presensitization may explain the mechanism of factor VIIa prophylaxis in factor VII-deficient patients
  - Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers
Novokhatny V. - Distinct dose-dependent effects of plasmin and TPA on coagulation and haemorrhage
Novokhatny V. - In vitro assessment of inhibitory potential of plasma and whole blood toward exogenous plasmin
Novokmet S. S. - Platelets–coronary endothelium interaction: focus on L-arginine:NO system
Novotny M. - A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A
  - The C1 domain substitution His2155Asp severely reduces factor VIII binding to von Willebrand factor
Nowak G. - Characterization of the urinary metabolites of dipetarudin
Nowak T. - Virus validation studies utilizing model viruses are relevant for west Nile virus
Nowak G. - Additive anti-angiogenic effects of trapidil and cyproheptadine in the chick area vasculosa angiogenesis model
  - Determination of direct thrombin inhibitors like hirudin in plasma – Comparison of the Ecarin Chromogenic Assay (ECA) with the Ecarin Clotting Time (ECT) and the Activated Partial Thromboplastin Time (APTT)
Nowak G. - PADA-HIT: A new POCT method for ultra-fast detection of HIT II antibodies
Nowak G. - PADA – fast and quantitative monitoring of blood platelet adhesiveness
Nowak-Goettl U. - Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
  - Sinus venous thrombosis in children – a multifactorial etiology
Nowak-Göttl U. - Factor XII-deficiency is a risk factor for ischaemic stroke but not for venous thrombosis in children
Noya M. S. - Replacement therapy for surgery and delivery in three patients from a single family with R1374C type 2M von Willebrand disease (VWD): the role of PFA100 monitoring
Nozzoli C. - Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
N'Tita K. - Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
Nuñez L. - Acquired platelet dysfunction with eosinophilia in children: A tropical disease present in Venezuela
Nugent D. J. - A proposed mechanism for reduced bleeding of direct thrombin inhibitors as compared to heparin as measured by thromboelastography
Nugent D. - Paradoxical effect of Factor XIII replacement on clot initiation
Nugent D. J. - Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
  - The laboratory evaluation of aspirin-resistance in normal, healthy subjects
Nurden A. T. - Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Nurden A. T. - Triple heterozygosity in the alphaIIb gene of a patient with Glanzmann thrombasthenia and platelets with a low alphaIIbbeta3 content
Nurden P. - Type 2N von Willebrand disease due to compound heterozygosity for the frequent R854Q type 2N mutation and a new R763G mutation abolishing the cleavage of von Willebrand factor propeptide
Nurden P. - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Nurden A. - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Nurden P. - Clinical and laboratory findings in a new case of congenital amegakaryocytic thrombocytopenia (CAMT)
Nurmohamed M. T. - Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Nuss R. - Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Nutescu E. A. - Factors that influence the prescribing of low-molecular-weight heparins (LMWHs) in community hospitals: opinions of physicians, clinical pharmacists, and formulary committee members
Nylander S. - The relative importance of P2Y12/P2Y1 in thrombin/ADP-induced platelet activation and true synergistic action in-between inhibition of P2Y12 and P2Y1